These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21436725

  • 1. Using metabolomics to decipher probiotic effects in patients with irritable bowel syndrome.
    Madsen K.
    J Clin Gastroenterol; 2011; 45(5):389-90. PubMed ID: 21436725
    [No Abstract] [Full Text] [Related]

  • 2. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
    Hong YS, Hong KS, Park MH, Ahn YT, Lee JH, Huh CS, Lee J, Kim IK, Hwang GS, Kim JS.
    J Clin Gastroenterol; 2011; 45(5):415-25. PubMed ID: 21494186
    [Abstract] [Full Text] [Related]

  • 3. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):463-73. PubMed ID: 17635381
    [Abstract] [Full Text] [Related]

  • 4. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M.
    Rev Esp Enferm Dig; 2009 Aug 01; 101(8):553-64. PubMed ID: 19785495
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
    Han K, Wang J, Seo JG, Kim H.
    J Gastroenterol; 2017 Apr 14; 52(4):432-443. PubMed ID: 27178566
    [Abstract] [Full Text] [Related]

  • 7. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y.
    J Clin Gastroenterol; 2011 Jul 14; 45(6):518-25. PubMed ID: 21436726
    [Abstract] [Full Text] [Related]

  • 8. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 9. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep 01; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 10. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 01; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 11. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Mar 01; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May 01; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 13. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V, Gschossmann J, Layer P.
    Lancet Gastroenterol Hepatol; 2020 Jul 01; 5(7):658-666. PubMed ID: 32277872
    [Abstract] [Full Text] [Related]

  • 14. Irritable Bowel Syndrome: Effects of a Probiotic Combination in Reducing Stress Response and Symptoms Associated With Irritable Bowel Syndrome.
    Ross SM.
    Holist Nurs Pract; 2020 Jul 01; 38(2):120-122. PubMed ID: 38363971
    [No Abstract] [Full Text] [Related]

  • 15. Probiotic agents in the treatment of irritable bowel syndrome.
    Guslandi M.
    J Int Med Res; 2007 Jul 01; 35(5):583-9. PubMed ID: 17900396
    [Abstract] [Full Text] [Related]

  • 16. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B.
    Nutrients; 2021 Feb 26; 13(3):. PubMed ID: 33652763
    [Abstract] [Full Text] [Related]

  • 17. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct 26; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 18. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM.
    Aliment Pharmacol Ther; 2009 Jan 26; 29(1):97-103. PubMed ID: 18785988
    [Abstract] [Full Text] [Related]

  • 19. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.
    Almansa C, Agrawal A, Houghton LA.
    Expert Rev Gastroenterol Hepatol; 2012 Jun 26; 6(3):383-98. PubMed ID: 22646259
    [Abstract] [Full Text] [Related]

  • 20. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC, Brostoff J, Whelan K, Sanderson JD.
    Am J Gastroenterol; 2008 Jun 26; 103(6):1557-67. PubMed ID: 18513268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.